Finance

Beta
Lists
MEDIF:OTCMKTS
Medipharm Labs Corp
$0.059
+5.58%
(+0.0031) 1D
Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MEDIF...
Open
$0.06
High
$0.06
Low
$0.05
Mkt. cap
27.88M
Avg. vol.
92.98K
Volume
40.77K
52-wk high
$0.08
52-wk low
$0.04
Beta
0.92
Shares outstanding
424.86M
No. of employees
127
Open
$0.06
High
$0.06
Low
$0.05
Mkt. cap
27.88M
Avg. vol.
92.98K
Volume
40.77K
52-wk high
$0.08
52-wk low
$0.04
Beta
0.92
Shares outstanding
424.86M
No. of employees
127
News stories
From sources across the web
About Medipharm Labs Corp
CEO-
Employees127
Founded2015
HeadquartersBarrie, Ontario, Canada
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
11.81M
11.45M
11.06M
8.96M
Cost of goods sold
8.44M
8.90M
7.26M
5.64M
Cost of revenue
8.44M
8.90M
7.26M
5.64M
Research and development expenses
46.00K
47.00K
52.00K
24.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.66M
4.50M
4.40M
4.14M
Operating expense
7.13M
4.74M
4.77M
4.23M
Total operating expenses
15.57M
13.64M
12.03M
9.88M
Operating income
-3.76M
-2.19M
-967.00K
-912.00K
Other non operating income
-
-
-
-
EBT including unusual items
-3.77M
-2.14M
-1.97M
-867.00K
EBT excluding unusual items
-3.73M
-2.14M
-965.00K
-867.00K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-78.00K
189.00K
358.00K
-84.00K
Net income
-3.77M
-2.14M
-1.97M
-867.00K
Net profit margin
-31.93%
-18.71%
-17.79%
-9.67%
Earnings per share
-
-
-
-
Interest and investment income
42.00K
62.00K
58.00K
60.00K
Interest expense
-12.00K
-16.00K
-19.00K
-15.00K
Net interest expenses
30.00K
46.00K
39.00K
45.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.35M
-1.78M
-580.00K
-530.00K
Gain or loss from assets sale
-190.00K
181.00K
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more